From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...

Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is back to buy the firm’s cancer tests. Labcorp is paying $192.5 million ...

Labcorp LH recently entered into an agreement with OPKO Health, Inc. OPK, a multinational biopharmaceutical and diagnostics company, to acquire select assets of the latter’s wholly owned subsidiary, ...

Labcorp Plasma Complete continues to be available for use in biopharmaceutical research in addition to its new application for clinical patient care. Labcorp Plasma Complete is a laboratory ...

Labcorp has reached an agreement to acquire BioReference Health's oncology diagnostic testing assets for up to $225 million upon closure of the transaction. The deal is expected to close in the ...

announced the clinical availability of Labcorp Plasma Complete, a circulating tumor DNA-based comprehensive genomic profiling solution for patients with advanced solid tumors. The liquid biopsy ...